S&P 500   3,335.38 (-0.48%)
DOW   27,451.81 (-0.48%)
QQQ   275.92 (-0.46%)
AAPL   114.04 (-0.80%)
MSFT   207.39 (-0.98%)
FB   261.56 (+1.85%)
GOOGL   1,460.99 (+0.16%)
AMZN   3,139.70 (-1.08%)
TSLA   419.00 (-0.52%)
NVDA   529.98 (+1.65%)
BABA   277.09 (+0.39%)
CGC   14.52 (+2.18%)
GE   6.16 (-0.65%)
MU   50.85 (+2.27%)
AMD   81.57 (+2.63%)
T   28.34 (-0.14%)
F   6.61 (-1.20%)
ACB   4.68 (-2.09%)
GILD   62.08 (-1.23%)
NFLX   492.63 (+0.40%)
DIS   124.98 (-0.80%)
BA   164.04 (-1.23%)
BAC   23.80 (-1.20%)
S&P 500   3,335.38 (-0.48%)
DOW   27,451.81 (-0.48%)
QQQ   275.92 (-0.46%)
AAPL   114.04 (-0.80%)
MSFT   207.39 (-0.98%)
FB   261.56 (+1.85%)
GOOGL   1,460.99 (+0.16%)
AMZN   3,139.70 (-1.08%)
TSLA   419.00 (-0.52%)
NVDA   529.98 (+1.65%)
BABA   277.09 (+0.39%)
CGC   14.52 (+2.18%)
GE   6.16 (-0.65%)
MU   50.85 (+2.27%)
AMD   81.57 (+2.63%)
T   28.34 (-0.14%)
F   6.61 (-1.20%)
ACB   4.68 (-2.09%)
GILD   62.08 (-1.23%)
NFLX   492.63 (+0.40%)
DIS   124.98 (-0.80%)
BA   164.04 (-1.23%)
BAC   23.80 (-1.20%)
S&P 500   3,335.38 (-0.48%)
DOW   27,451.81 (-0.48%)
QQQ   275.92 (-0.46%)
AAPL   114.04 (-0.80%)
MSFT   207.39 (-0.98%)
FB   261.56 (+1.85%)
GOOGL   1,460.99 (+0.16%)
AMZN   3,139.70 (-1.08%)
TSLA   419.00 (-0.52%)
NVDA   529.98 (+1.65%)
BABA   277.09 (+0.39%)
CGC   14.52 (+2.18%)
GE   6.16 (-0.65%)
MU   50.85 (+2.27%)
AMD   81.57 (+2.63%)
T   28.34 (-0.14%)
F   6.61 (-1.20%)
ACB   4.68 (-2.09%)
GILD   62.08 (-1.23%)
NFLX   492.63 (+0.40%)
DIS   124.98 (-0.80%)
BA   164.04 (-1.23%)
BAC   23.80 (-1.20%)
S&P 500   3,335.38 (-0.48%)
DOW   27,451.81 (-0.48%)
QQQ   275.92 (-0.46%)
AAPL   114.04 (-0.80%)
MSFT   207.39 (-0.98%)
FB   261.56 (+1.85%)
GOOGL   1,460.99 (+0.16%)
AMZN   3,139.70 (-1.08%)
TSLA   419.00 (-0.52%)
NVDA   529.98 (+1.65%)
BABA   277.09 (+0.39%)
CGC   14.52 (+2.18%)
GE   6.16 (-0.65%)
MU   50.85 (+2.27%)
AMD   81.57 (+2.63%)
T   28.34 (-0.14%)
F   6.61 (-1.20%)
ACB   4.68 (-2.09%)
GILD   62.08 (-1.23%)
NFLX   492.63 (+0.40%)
DIS   124.98 (-0.80%)
BA   164.04 (-1.23%)
BAC   23.80 (-1.20%)
Log in
NASDAQ:UTHR

United Therapeutics Earnings Date, Estimates & History

$101.01
-0.50 (-0.49 %)
(As of 09/29/2020 03:44 PM ET)
Add
Compare
Today's Range
$100.26
Now: $101.01
$101.55
50-Day Range
$99.90
MA: $105.86
$112.79
52-Week Range
$75.58
Now: $101.01
$127.79
Volume3,493 shs
Average Volume527,105 shs
Market Capitalization$4.49 billion
P/E Ratio10.37
Dividend YieldN/A
Beta0.74

Earnings

United Therapeutics (NASDAQ:UTHR) Earnings Information

United Therapeutics last released its quarterly earnings data on July 29th, 2020. The biotechnology company reported $2.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.41. The company had revenue of $362 million for the quarter, compared to analyst estimates of $339.97 million. Its quarterly revenue was down 3.1% compared to the same quarter last year. United Therapeutics has generated ($2.39) earnings per share over the last year and currently has a price-to-earnings ratio of 10.4. United Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

United Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

United Therapeutics (NASDAQ:UTHR) Earnings Estimates

2020 EPS Consensus Estimate: $9.14
2021 EPS Consensus Estimate: $8.96
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202$2.04$2.52$2.28
Q2 20202$2.07$3.23$2.65
Q3 20202$1.95$2.40$2.18
Q4 20202$1.81$2.26$2.04
Q1 20211$3.38$3.38$3.38
Q2 20211$2.24$2.24$2.24
Q3 20211$1.57$1.57$1.57
Q4 20211$1.77$1.77$1.77

United Therapeutics (NASDAQ UTHR) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020
(Estimated)
       
7/29/20206/30/2020$2.41$2.41$2.41$339.97 million$362.00 millionTranscript
4/29/20203/31/2020$2.43$3.12$3.12$343.68 million$356.30 millionTranscript
2/26/2020Q4 2019$2.47$1.20$1.20$357.14 million$311.10 millionTranscript
10/30/2019Q3 2019$2.34$3.16$3.01$342.28 million$401.50 millionTranscript
7/31/2019Q2 2019$2.40$4.66$4.66$331.78 million$373.60 millionN/A
5/1/20193/31/2019$2.64($11.32)($11.32)$335.72 million$362.70 millionN/A
2/27/2019Q4 2018$2.20$1.48$1.48$355.81 million$381.40 millionListen
10/31/20189/30/2018$3.23$2.42$2.42$378.22 million$412.70 millionN/A
8/1/2018Q2 2018$2.57$3.98$3.98$368.63 million$444.50 millionN/A
5/2/2018Q1 2018$3.6170$5.57$5.57$393.96 million$389.20 millionN/A
2/21/2018Q4 2017$3.59$3.89$3.69$420.55 million$464.70 millionN/A
10/25/2017Q3 2017$4.01$6.27$6.27$426.43 million$445.50 millionN/A
7/27/2017Q2 2017$3.61($1.25)($1.25)$391.53 million$444.60 millionN/A
4/26/2017Q1 2017$3.1250$3.89$3.89$399.59 million$370.50 millionN/A
2/22/2017Q4 2016$3.62$2.43$2.43$415.51 million$409.00 millionListen
10/27/2016Q3 2016$3.47$3.50$3.50$400.58 million$408.20 millionListen
7/28/2016Q2 2016$3.26$4.39$4.39$395.15 million$412.60 millionListen
4/28/2016Q1 2016$3.33$4.84$4.84$395.02 million$369.00 millionListen
2/25/2016Q4 2015$2.57$2.10$2.10$388.29 million$404.90 millionListen
10/27/2015Q3 2015$2.44$5.02$0.80$363.51 million$386.20 millionListen
7/28/2015Q2 2015$2.26$2.02$2.13$360.41 million$347.20 millionListen
4/28/2015Q1 2015$2.10($0.22)($0.08)$353.50 million$327.60 millionN/A
2/24/2015Q4 2014$2.19$2.17$2.17$336.22 million$346.40 millionN/A
10/28/2014Q3 2014$1.84($0.53)($0.53)$335.10 million$330.00 millionN/A
7/29/2014Q2 2014$1.66$2.10$2.10$308.04 million$322.80 millionN/A
4/29/2014Q1 2014$1.57$2.64$2.85$300.14 million$289.40 millionListen
2/25/2014Q4 2013$1.69($0.60)($0.60)$295.43 million$289.02 millionListen
10/29/2013Q3 2013$1.60$1.17$1.17$279.02 million$302.20 millionListen
7/25/2013Q2 2013$1.47$1.52$1.52$250.17 million$280.60 millionN/A
4/25/2013Q1 2013$1.47$1.19$1.19$241.14 million$245.14 millionTranscript
2/26/2013Q4 2012$1.25$1.65$233.41 million$243.82 millionN/A
11/1/2012Q312$1.26$2.82$227.63 million$242.50 millionN/A
7/26/2012$1.23$1.34Transcript
4/26/2012$1.00$1.32N/A
2/14/2012$0.85$0.77Listen
10/27/2011$0.88$1.32N/A
7/28/2011$0.49$1.27N/A
4/28/2011$0.64$1.29Transcript
2/15/2011$0.62$0.15N/A
10/28/2010Q3 2010$0.54$0.66$0.66N/A
7/28/2010Q2 2010$0.45$0.62$0.62N/A
4/29/2010Q1 2010$0.30$0.32$0.32N/A
2/16/2010Q4 2009$0.28$0.16$0.38N/A
10/29/2009Q3 2009$0.34$0.21$0.21N/A
7/31/2009Q2 2009$0.28($0.05)($0.05)N/A
5/1/2009Q1 2009$0.31$0.24$0.24N/A
2/17/2009Q4 2008$0.26$0.43$2.57N/A
10/30/2008Q3 2008$0.30$0.25$0.25N/A
7/31/2008Q2 2008$0.30$0.29$0.29N/A
5/1/2008Q1 2008$0.27$0.24$0.24N/A
2/19/2008Q4 2007$0.25$0.04$0.04N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.